Select Page

The Cancer Frontier: Managing Symptoms & More Copy

An overview of cannabis for symptom management related to mainstream cancer treatments, including medication interactions plus emerging science about cancer inhibition by cannabinoids. Learn about framing cannabis in cancer management in the context of evidence, appropriate usage scenarios, and suggested protocols for incorporating cannabis as an anticancer agent will be covered, along with an overview of combination botanical strategies for cancer care.

Faculty:
Jonathan Treasure, MNIMH, MCPP
Medical Herbalist

Modulating Women’s Health with an Ancient Plant Copy

Our endocannabinoid levels are tied closely to estrogen levels, and when they dip, women feel the effects of endocannabinoid deficiency. Learn how cannabinoid supplementation along with other botanicals can stabilize mood, reduce pelvic pain, improve cognition and even offset the symptoms of menopause.

Faculty:
Michele Ross, PhD
Founder, IMPACT Network

Cannabis Pharmacokinetics: Considerations for Dose, Absorption & Bioavailability

While cannabis is a plant with diverse phytochemicals that work synergistically, solvent extracts of cannabis or preparations made from these extracts high in active cannabinoids are also available. These preparations can be more similar to concentrated, single-entity pharmaceutical drugs. Explore how the two most studied cannabinoids – THC and CBD – are metabolized by and affect the body via different routes of administration.

Faculty:
Kate Welch, PharmD
Founder, Delta Nine Solutions

The Endocannabinoid System: Deep Dive Copy

An advanced look at the endocannabinoid system, or ECS, covering the unique retrograde signaling in the brain, the known polymorphisms, the pharmokinetics, the gender differences + the modulators of the ECS. Building on the foundational ECS module in Track I, take a deep dive into the intricacies + nuances of this complex system.

Faculty:
Lex Pelger
Scientist, Educator + Host, Psymposia

Exit Herb from Addiction Copy

Opioid addiction is at crisis level in the US and around the world. Progressive practitioners and patients alike are lobbying for cannabis is as first-line therapy for opioid, alcohol, and other substance rehabilitation. Understand the conditions and situations where cannabis is and is not appropriate as an exit tool.

Faculty:
Mary Lynn Mathre, RN, MSN, CARN